Two Sigma Securities’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,141
Closed -$43.8K 3028
2023
Q4
$43.8K Buy
+22,141
New +$19.3K ﹤0.01% 2624
2023
Q3
Sell
-25,213
Closed -$28.7K 2985
2023
Q2
$28.7K Buy
25,213
+2,916
+13% +$2.54K ﹤0.01% 2463
2023
Q1
$15.7K Buy
+22,297
New +$18.3K ﹤0.01% 2397
2022
Q4
Sell
-36,251
Closed -$24K 2651
2022
Q3
$24K Buy
+36,251
New +$51.2K ﹤0.01% 2275
2022
Q1
Sell
-17,536
Closed -$75K 2144
2021
Q4
$75K Buy
+17,536
New +$94.9K ﹤0.01% 1211
2018
Q1
Sell
-30,804
Closed -$77K 2685
2017
Q4
$77K Buy
+30,804
New +$91.6K ﹤0.01% 1484

Other funds holding CGEN

Two Sigma Securities's CGEN Position: Q1 2024 in Review

Two Sigma Securities sold out of Compugen (CGEN) in Q1 2024, closing a stake of 22,141 shares — an estimated $43.8K sold.

Two Sigma Securities first reported a position in CGEN in Q4 2017 and held it in 6 quarters. The position peaked at $77K in Q4 2017. 73 funds tracked by Wall St. Rank hold CGEN as of Q1 2024.

  • Two Sigma Securities reported no remaining Compugen position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 22,141 Compugen shares in Q1 2024, an estimated $43.8K.
  • Two Sigma Securities first reported a position in Compugen in Q4 2017 and held it in 6 quarters.
  • Two Sigma Securities's Compugen position peaked at $77K in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Compugen as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.